Location: Home
  • search
  • go
  • Relate News
  • 11/27/2018China Approved 30 New Drugs from Foreign Countries in the Past 21 Mont...
  • 11/27/2018Hikma Pharma to Sell Hansoh Pharma's Injectable Anticancers in the U.S...
  • 11/26/2018Gene-Edited Babies: China Wants To Be The World Leader, But At What Co...
  • 11/26/2018NHC and SATCM Issue New Pharmacy Service Policy, Banning Contract Mana...
  • 11/26/2018CPA: Review of Chinese Hospital Drug Market Changes in the Past Five Y...
  • 11/26/2018Chi-Med and Eli Lilly Announce First Commercial Launch of Fruquintinib...
  • 11/23/2018Recent Executive Moves
  • 11/23/2018MOFCOM Solicits Comments on Draft Guidelines for National Classificati...
  • 11/23/2018National Pharmacopoeia Commission Solicits Comments on Guide for Gener...
  • 11/22/2018Trump Administration Accuses China of Unfairly Using Venture Capital t...
  • 11/20/2018Sanofi China to Open New $114M Research Site in Suzhou
  • 11/20/2018Alphamab raises $100M in Series A financing from US, Asian investors
  • 11/19/2018Huadong Medicine Completes Acquisition of U.K.'s Sinclair Pharma
  • 11/16/2018Chi-Med Announces Negative Results of Phase III Chinese Trial for Fruq...
  • 11/16/2018NMPA Grants Priority Review to BeiGene's NDAs for Zanubrutinib and Tis...
  • 11/15/2018MorphoSys and I-Mab Enter Strategic Alliance for MorphoSys's Novel I/O...
  • 11/15/2018President Xi Pledges to Protect IP and Boost Import at 1st Import Expo
  • 11/14/2018U.S. Trade Union Urges USFDA to Investigate GNC Acquisition by Harbin ...
  • 11/13/2018CFIUS Broadens Coverage of Cross-Border Biotech Transactions
  • 11/12/2018Innovent Files Chinese NDA for Humira Biosimilar IBI303
  • 11/12/2018In China, Desperate Patients Smuggle Drugs. Or Make Their Own.
  • 11/12/2018Merck to Quadruple Gardasil Supply in China to Meet Fast-rising Demand
  • 11/12/2018Leading MNCs Tout Renewed China Business Growth in Q3
  • 11/12/2018BeiGene Delays US Filing for BTK Inhibitor Zanubrutinib
  • 11/12/2018Eisai Launches HCC Drug LENVIMA (lenvatinib) in China
  • 11/12/2018SAMR Solicits Comments on Production Licensing Regulation for Formulat...
  • 11/11/2018Merck KGaA Paves the Way for its Innovation Hub in Southern China
  • 11/9/2018Performance of Chinese Pharmaceutical Industry on Steady Growth in 3Qs...
  • 11/9/2018Recent Executive Moves
  • 11/8/2018Amyris Further Expands Relationship with Yifan Pharma
  • Page:166/371 Total number of articles:11124: [First][<<] [164] [165] [166] [167] [168] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group